Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Smart city leader: Can technology predict deadly shooters before it’s too late?
A smart city is a safe city, Herb Sih said. And technology can help. “If you don’t have safety, you don’t have anything,” said Sih, managing partner at Think Big Partners, one of the key collaborators in Kansas City’s $15.7 million public-private Smart City initiative. Having grown up in St. Louis, Sih said he has…
T-shirt printer GOEX hopes to clad workers in dignity
A Kansas City T-shirt screen printer has a lofty mission: Turn local purchases into global impact. “Your dollar has value in how it’s treating others across the world,” said Ryan Hudnall, engagement director at the Global Orphan Project. Tucked away near Wyandotte and 31st streets, GOEX serves as an offshoot of the Global Orphan Project,…
Looping back? Missouri partners with Hyperloop to study 23-minute KC-St Louis route
Missouri’s prospects for landing a Hyperloop route apparently aren’t off the rails after all. Despite the company revealing four U.S. finalist routes in September — which did not include a proposed route through the Show Me State – Hyperloop One announced Tuesday it has entered into a public-private partnership with the State of Missouri to conduct…
Techstars Spotlight: GRIT Virtual builds 3-D tech into 2-D construction mindset
3-D should stay 3-D, said Chris Callen, CEO of GRIT Virtual. And with the rise of virtual reality and augmented reality technology, that philosophy can be applied to the construction of 3-D buildings, Callen said. Wichita-based GRIT Virtual is a software-as-a-service platform for large contractors. It uses VR software to streamline the workflow for construction…